Profiles of Medicare Beneficiaries with Medicaid Drug Coverage Prior to the Medicare Drug Benefit PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Profiles of Medicare Beneficiaries with Medicaid Drug Coverage Prior to the Medicare Drug Benefit PDF full book. Access full book title Profiles of Medicare Beneficiaries with Medicaid Drug Coverage Prior to the Medicare Drug Benefit by Henry J. Kaiser Family Foundation. Download full books in PDF and EPUB format.
Author: Henry J. Kaiser Family Foundation
Publisher:
ISBN:
Category :
Languages : en
Pages : 5
Get Book Here
Book Description
Author: Henry J. Kaiser Family Foundation
Publisher:
ISBN:
Category :
Languages : en
Pages : 5
Get Book Here
Book Description
Author: Laura A. Dummit
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 24
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 70
Get Book Here
Book Description
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442
Get Book Here
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Author: United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 86
Get Book Here
Book Description
Author: United States. Social and Rehabilitation Service
Publisher:
ISBN:
Category : Medicaid
Languages : en
Pages : 460
Get Book Here
Book Description
Author: Kaiser Commission on Medicaid and the Uninsured
Publisher:
ISBN:
Category :
Languages : en
Pages : 11
Get Book Here
Book Description
Author:
Publisher: U.S. Government Printing Office
ISBN:
Category : Business & Economics
Languages : en
Pages : 94
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: United States Government Accountability Office
Publisher: Createspace Independent Publishing Platform
ISBN: 9781976361715
Category :
Languages : en
Pages : 88
Get Book Here
Book Description
On January 1, 2006, Medicare began providing coverage for outpatient prescription drugs through its new Part D benefit. Beneficiaries who enroll in Part D may choose a drug plan from those offered by private plan sponsors under contract to the Centers for Medicare & Medicaid Services (CMS), which administers the Part D benefit. Beneficiaries have until May 15, 2006, to enroll in the Part D benefit and select a plan without the risk of penalties. GAO was asked to review the quality of CMS's communications on the Part D benefit. GAO examined 70 CMS publications to select 6 documents for review and contracted with the American Institutes for Research to evaluate the clarity of these texts; made 500 calls to the 1-800-MEDICARE help line; and contracted with the Nielsen Norman Group to evaluate the usability of the Medicare Web site.
